Sales in the global Bioimpedance Devices Market are slated to top US$ 492.1 Mn in 2022. Expanding at a healthy 6.4% CAGR, the market size is projected to total US$ 715.1 Mn by 2028.Increasing cases of CKD diseases are expected to contribute to the growth of the Bioimpedance Devices Market throughout the forecast per.
Bioimpedance Devices Market size is projected to total US$ 715 1 Million by 2028 - Comprehensive Research Report by FMI forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ALEXANDRIA, Va., April 30, 2021 /PRNewswire/ A 2020 FDA-funded report published by the National Academies of Sciences, Engineering, and Medicine (NASEM) on the safety and utility of compounded hormones is compromised by potential bias, conflicts of interest and bad science so says an independent, third-party analysis of the NASEM report released today.
The Food and Drug Administration (FDA) touted the NASEM report, which recommended restrictions on compounded hormone therapy, as independent and comprehensive, but in fact it was neither. That s one of the key findings in the white paper by Dr. Alyson Wooten, a director at the nonpartisan Berkeley Research Group (BRG). The paper is titled